NATIONAL INSTITUTES OF HEALTH has floated a tender for Institutional Training Programs to Advance Translational Research on Alzheimer``s Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed). The project location is USA and the tender is closing on 07 Jan 2021. The tender notice number is PAR-18-524, while the TOT Ref Number is 19317319. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Institutional Training Programs to Advance Translational Research on Alzheimer``s Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)

Deadline : 07 Jan 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 19317319

Document Ref. No. : PAR-18-524

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV

Tender Details

Tender are invited for Institutional Training Programs to Advance Translational Research on Alzheimer``s Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed)

CFDA Number : 93.866 -- Aging Research

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Jan 07, 2021

Posted Date : Dec 21, 2017

Description: This Funding Opportunity Announcement (FOA) seeks to enable the development of a diverse, translational research workforce capable of participating and/or leading cross-disciplinary team science programs focused on advancing therapy development for Alzheimer``s disease (AD) and AD-related dementias. This FOA will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e. basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational and clinical research for AD and AD-related dementias.

Documents

 Tender Notice